Pharmaceutical water, also known as purified water, is widely used in the production of pharmaceutical formulations in order to ensure safety and effectiveness of drugs. Pharmaceutical water goes through stringent purification processes to remove suspended particles, bacteria, endotoxins and other contaminants.
The global pharmaceutical water market is estimated to be valued at US$ 7.22 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the pharmaceutical water market are Heidelberg Printing Machinery AG,Komori Corporation,Koenig & Bauer AG,Manroland Goss web systems,HP Inc.,Xerox Corporation,Canon Inc.,Ricoh Company, Ltd.,Epson,Konica Minolta, Inc. The stringent regulations regarding quality of water in pharmaceutical manufacturing is creating growth opportunities for pharmaceutical grade water suppliers and providers of water purification equipment and technologies. Major players are expanding their presence globally particularly in emerging markets to tap the growth opportunities.
Key players operating in the pharmaceutical water market are Heidelberg Printing Machinery AG,Komori Corporation,Koenig & Bauer AG,Manroland Goss web systems,HP Inc.,Xerox Corporation,Canon Inc.,Ricoh Company, Ltd.,Epson,Konica Minolta, Inc. The stringent regulations imposed by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) regarding purity levels in water used across various stages of pharmaceutical manufacturing is presenting lucrative growth opportunities for Pharmaceutical Water Market Size suppliers.
Furthermore, growing generics market and expansion of pharmaceutical companies in emerging economies is driving the demand for pharmaceutical water and subsequently fuelling the growth of the global pharmaceutical water market.
Market drivers
The global pharmaceutical water market is witnessing robust growth owing to the stringent regulations introduced by regulatory bodies such as the FDA regarding traceability and quality of water used in pharmaceutical manufacturing. The FDA has published guidelines such as USP standards which outlines the different grades and types of water required at various stages of drug manufacturing process requiring the use of ultrapure water to remove even trace impurities. This is creating significant demand for advanced water purification technologies and systems to meet the quality standards set by regulatory authorities globally.
PEST Analysis
Political: Regulations over Pharmaceutical Water Market manufacturing standards and environment compliance will continue to increase production costs.
Economic: Rising healthcare expenditure globally along with increasing R&D investments by pharma companies are driving demand for highly purified water in manufacturing.
Social: Growing awareness about water-borne diseases and importance of clean drinking water will boost consumption of purified water.
Technological: Advanced water purification technologies like reverse osmosis, ultrafiltration and ion exchange are being increasingly used to produce high purity grade water required in pharmaceutical applications.
North America accounts for the largest share of the pharmaceutical water market in terms of value mainly due to stringent regulatory landscape, extensive R&D activities and large pharmaceutical production. The region is also a pioneer in adopting latest water purification technologies. Asia Pacific is projected to be the fastest growing regional market driven by expanding pharmaceutical industry, rising healthcare expenditure and increasing government focus on ensuring clean drinking water. Countries like India, China and Japan are major manufacturing hubs and see growing need for high quality water in pharma production.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
